Your In Treatment-Control Designs Days or Less
Next, we would remove the treatment from the group of patients with depression. The switch back and multiple switchback designs are of emerging relevance with the advent of biosimilars where switchability and interchangeability of a biosimilar to a bio-originator molecule can only be confirmed by such trial designs. This design could be improved by locating […]